EQT Private Equity Acquires SPT Labtech from Battery Ventures for GBP 650 million

K-Sport Acquires 67% Stake in Sports Performance Tracking (SPT)

April 2, 2025

AI & Machine Learning

Italian sports-technology company K-Sport has acquired a 67% stake in Australian wearable-technology and analytics provider Sports Performance Tracking (SPT). The deal gives K-Sport direct access to SPT’s established customer base in the United States and Asia-Pacific and will combine K-Sport’s AI-driven match analysis with SPT’s commercial presence to accelerate international expansion and product capability development.

EQT Acquires Mabtech from IK Partners and Mérieux Equity Partners

January 9, 2024

Biotechnology

EQT, via its newly launched EQT Healthcare Growth Strategy, is acquiring Swedish immunoassay specialist Mabtech AB from IK Partners and Mérieux Equity Partners. Mabtech, a developer and manufacturer of antibodies, kits and readers used in vaccine, infectious disease and oncology research, will be supported by EQT to expand its product portfolio and accelerate geographic growth, particularly in the US. The transaction is subject to customary regulatory approvals and financial terms were not disclosed.

Battery Ventures Acquires Skalar Analytical, PromoChrom and LCTech to Create Laboratory-Automation Platform

September 28, 2023

Manufacturing

Battery Ventures announced investments to create a new laboratory-automation platform built around Skalar Analytical (the foundation) and add-on companies PromoChrom Technologies and LCTech. The platform will serve environmental, agricultural and food & beverage testing markets by combining automated chemistry analyzers, SPE sample-preparation solutions, consumables and robotics to drive global growth and further M&A.

EQT Acquires LSP (Life Sciences Partners)

November 10, 2021

Financial Services

EQT AB has acquired LSP (Life Sciences Partners), a leading European life-sciences venture capital firm, in a transaction that creates a new EQT Life Sciences business line. The deal values the upfront consideration at EUR 450 million (25% cash / 75% EQT shares) with a EUR 25 million earn‑out paid on meeting fundraising targets (total consideration EUR 475 million at close); LSP's 34-person team and partners join EQT to strengthen its healthcare investing capabilities.

SPT Labtech Acquires BioMicroLab

February 15, 2021

Medical Devices

SPT Labtech has acquired BioMicroLab, a Northern California-based provider of benchtop robotics and laboratory automation systems. The acquisition expands SPT Labtech's sample management and automation capabilities, creating a more comprehensive end-to-end solution for life science laboratories.

SPT Labtech Acquires Apricot Designs

January 20, 2021

Medical Devices

SPT Labtech has acquired Apricot Designs Inc., a Covina, California-based designer and manufacturer of multichannel micro-volume pipettors and sample preparation devices. The deal expands SPT Labtech's liquid handling and sample preparation capabilities and strengthens its presence in the U.S. and Asian markets.